Why This Matters
Tens of millions of Americans are now taking or are about to start a GLP-1 receptor agonist for weight loss, obesity management, or type 2 diabetes. Most are focused on what the drugs do for their weight, blood sugar, and cardiovascular risk. Few are asking what these drugs may be doing to their bones.